Roche Gets FDA Approval for Anemia Drug Mircera

Roche Holdings AG said that the U.S. Food and Drug Administration (FDA) has approved Micera for the treatment of anemia associated with chronic renal failure in adults, including patients on dialysis and patients not on dialysis.
CNN Money